Global Active Pharma Ingredient Market Insights, Forecast to 2025
Table of Content
Table of Contents
Executive Summary
1 Industry Overview of Active Pharma Ingredient
- 1.1 Definition of Active Pharma Ingredient
- 1.2 Active Pharma Ingredient Segment by Type
- 1.2.1 Global Active Pharma Ingredient Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Innovative Active Pharmaceutical Ingredients
- 1.2.3 Generic Active Pharmaceutical Ingredients
- 1.3 Active Pharma Ingredient Segment by Applications
- 1.3.1 Global Active Pharma Ingredient Consumption Comparison by Applications (2014-2025)
- 1.3.2 Oncology
- 1.3.3 Cardiovascular Disease
- 1.3.4 Diabetes
- 1.3.5 Central Nervous System and Neurological Disorders
- 1.3.6 Endocrinology
- 1.3.7 Other Therapeutic Applications
- 1.4 Global Active Pharma Ingredient Overall Market
- 1.4.1 Global Active Pharma Ingredient Revenue (2014-2025)
- 1.4.2 Global Active Pharma Ingredient Production (2014-2025)
- 1.4.3 North America Active Pharma Ingredient Status and Prospect (2014-2025)
- 1.4.4 Europe Active Pharma Ingredient Status and Prospect (2014-2025)
- 1.4.5 China Active Pharma Ingredient Status and Prospect (2014-2025)
- 1.4.6 Japan Active Pharma Ingredient Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Active Pharma Ingredient Status and Prospect (2014-2025)
- 1.4.8 India Active Pharma Ingredient Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Active Pharma Ingredient
- 2.3 Manufacturing Process Analysis of Active Pharma Ingredient
- 2.4 Industry Chain Structure of Active Pharma Ingredient
3 Development and Manufacturing Plants Analysis of Active Pharma Ingredient
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Active Pharma Ingredient Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Active Pharma Ingredient
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Active Pharma Ingredient Production and Capacity Analysis
- 4.2 Active Pharma Ingredient Revenue Analysis
- 4.3 Active Pharma Ingredient Price Analysis
- 4.4 Market Concentration Degree
5 Active Pharma Ingredient Regional Market Analysis
- 5.1 Active Pharma Ingredient Production by Regions
- 5.1.1 Global Active Pharma Ingredient Production by Regions
- 5.1.2 Global Active Pharma Ingredient Revenue by Regions
- 5.2 Active Pharma Ingredient Consumption by Regions
- 5.3 North America Active Pharma Ingredient Market Analysis
- 5.3.1 North America Active Pharma Ingredient Production
- 5.3.2 North America Active Pharma Ingredient Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Active Pharma Ingredient Import and Export
- 5.4 Europe Active Pharma Ingredient Market Analysis
- 5.4.1 Europe Active Pharma Ingredient Production
- 5.4.2 Europe Active Pharma Ingredient Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Active Pharma Ingredient Import and Export
- 5.5 China Active Pharma Ingredient Market Analysis
- 5.5.1 China Active Pharma Ingredient Production
- 5.5.2 China Active Pharma Ingredient Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Active Pharma Ingredient Import and Export
- 5.6 Japan Active Pharma Ingredient Market Analysis
- 5.6.1 Japan Active Pharma Ingredient Production
- 5.6.2 Japan Active Pharma Ingredient Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Active Pharma Ingredient Import and Export
- 5.7 Southeast Asia Active Pharma Ingredient Market Analysis
- 5.7.1 Southeast Asia Active Pharma Ingredient Production
- 5.7.2 Southeast Asia Active Pharma Ingredient Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Active Pharma Ingredient Import and Export
- 5.8 India Active Pharma Ingredient Market Analysis
- 5.8.1 India Active Pharma Ingredient Production
- 5.8.2 India Active Pharma Ingredient Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Active Pharma Ingredient Import and Export
6 Active Pharma Ingredient Segment Market Analysis (by Type)
- 6.1 Global Active Pharma Ingredient Production by Type
- 6.2 Global Active Pharma Ingredient Revenue by Type
- 6.3 Active Pharma Ingredient Price by Type
7 Active Pharma Ingredient Segment Market Analysis (by Application)
- 7.1 Global Active Pharma Ingredient Consumption by Application
- 7.2 Global Active Pharma Ingredient Consumption Market Share by Application (2014-2019)
8 Active Pharma Ingredient Major Manufacturers Analysis
- 8.1 Teva
- 8.1.1 Teva Active Pharma Ingredient Production Sites and Area Served
- 8.1.2 Teva Product Introduction, Application and Specification
- 8.1.3 Teva Active Pharma Ingredient Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Novartis
- 8.2.1 Novartis Active Pharma Ingredient Production Sites and Area Served
- 8.2.2 Novartis Product Introduction, Application and Specification
- 8.2.3 Novartis Active Pharma Ingredient Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Pfizer
- 8.3.1 Pfizer Active Pharma Ingredient Production Sites and Area Served
- 8.3.2 Pfizer Product Introduction, Application and Specification
- 8.3.3 Pfizer Active Pharma Ingredient Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Johnson & Johnson
- 8.4.1 Johnson & Johnson Active Pharma Ingredient Production Sites and Area Served
- 8.4.2 Johnson & Johnson Product Introduction, Application and Specification
- 8.4.3 Johnson & Johnson Active Pharma Ingredient Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Mylan
- 8.5.1 Mylan Active Pharma Ingredient Production Sites and Area Served
- 8.5.2 Mylan Product Introduction, Application and Specification
- 8.5.3 Mylan Active Pharma Ingredient Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 North China Pharmaceutical Group
- 8.6.1 North China Pharmaceutical Group Active Pharma Ingredient Production Sites and Area Served
- 8.6.2 North China Pharmaceutical Group Product Introduction, Application and Specification
- 8.6.3 North China Pharmaceutical Group Active Pharma Ingredient Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Dr. Reddy’s Laboratories
- 8.7.1 Dr. Reddy’s Laboratories Active Pharma Ingredient Production Sites and Area Served
- 8.7.2 Dr. Reddy’s Laboratories Product Introduction, Application and Specification
- 8.7.3 Dr. Reddy’s Laboratories Active Pharma Ingredient Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Roche
- 8.8.1 Roche Active Pharma Ingredient Production Sites and Area Served
- 8.8.2 Roche Product Introduction, Application and Specification
- 8.8.3 Roche Active Pharma Ingredient Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Aurobindo pharma
- 8.9.1 Aurobindo pharma Active Pharma Ingredient Production Sites and Area Served
- 8.9.2 Aurobindo pharma Product Introduction, Application and Specification
- 8.9.3 Aurobindo pharma Active Pharma Ingredient Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Sun Pharmaceutical Industries
- 8.10.1 Sun Pharmaceutical Industries Active Pharma Ingredient Production Sites and Area Served
- 8.10.2 Sun Pharmaceutical Industries Product Introduction, Application and Specification
- 8.10.3 Sun Pharmaceutical Industries Active Pharma Ingredient Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Boehringer Ingelheim GmbH
- 8.12 Bayer
- 8.13 BASF
- 8.14 DSM
- 8.15 Zhejiang Medicine
- 8.16 Biocon
- 8.17 Johnson Matthey
- 8.18 Hisun Pharmacy
- 8.19 Cambrex
- 8.20 Shandong Xinhua Pharmaceutical
- 8.21 Lonza group
- 8.22 Huahai Pharmaceutical
- 8.23 Haerbin Pharmaceutical Group
- 8.24 Cipla
- 8.25 Tian Yao
- 8.26 Lupin
- 8.27 North East Pharmaceutical
- 8.28 Albemarle
- 8.29 Shandong Lukang Pharmaceutical
- 8.30 Jiangsu Hengrui Medicine
9 Development Trend of Analysis of Active Pharma Ingredient Market
- 9.1 Global Active Pharma Ingredient Market Trend Analysis
- 9.1.1 Global Active Pharma Ingredient Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Active Pharma Ingredient Regional Market Trend
- 9.2.1 North America Active Pharma Ingredient Forecast 2019-2025
- 9.2.2 Europe Active Pharma Ingredient Forecast 2019-2025
- 9.2.3 China Active Pharma Ingredient Forecast 2019-2025
- 9.2.4 Japan Active Pharma Ingredient Forecast 2019-2025
- 9.2.5 Southeast Asia Active Pharma Ingredient Forecast 2019-2025
- 9.2.6 India Active Pharma Ingredient Forecast 2019-2025
- 9.3 Active Pharma Ingredient Market Trend (Product Type)
- 9.4 Active Pharma Ingredient Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Active Pharma Ingredient Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Description
The global Active Pharma Ingredient market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Active Pharma Ingredient volume and value at global level, regional level and company level. From a global perspective, this report represents overall Active Pharma Ingredient market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Active Pharma Ingredient in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Active Pharma Ingredient manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Teva
Novartis
Pfizer
Johnson & Johnson
Mylan
North China Pharmaceutical Group
Dr. Reddy’s Laboratories
Roche
Aurobindo pharma
Sun Pharmaceutical Industries
Boehringer Ingelheim GmbH
Bayer
BASF
DSM
Zhejiang Medicine
Biocon
Johnson Matthey
Hisun Pharmacy
Cambrex
Shandong Xinhua Pharmaceutical
Lonza group
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
Cipla
Tian Yao
Lupin
North East Pharmaceutical
Albemarle
Shandong Lukang Pharmaceutical
Jiangsu Hengrui Medicine
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Innovative Active Pharmaceutical Ingredients
Generic Active Pharmaceutical Ingredients
Segment by Application
Oncology
Cardiovascular Disease
Diabetes
Central Nervous System and Neurological Disorders
Endocrinology
Other Therapeutic Applications